Skip to search formSkip to main contentSkip to account menu

ibopamine

Known as: N-methyldopamine diisobutyrate, Propanoic acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene ester 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Summary: The effects of 100 mg ibopamine, an orally active aselective dopamine (DA) agonist, on plasma catecholamines was… 
1990
1990
1. Ibopamine is a new orally active inodilator, which is developed for the treatment of congestive heart failure (CHF). We… 
1989
1989
Ibopamine, a dopamine derivative suitable for oral administration, is reported to improve cardiac function in patients with… 
1986
1986
The aim of the present investigation was to evaluate the acute hemodynamic effects of a single oral dose of 200 mg ibopamine (SB… 
1986
1986
In order to describe kinetics after single administration and to test dose independence in the therapeutic dose range, ibopamine… 
1986
1986
A technique is described for measuring an index of cardiac output, total and individual renal plasma flow, cortical and… 
1986
1986
The pharmacological activity of ibopamine (SB-7505), the 3,4-diisobutyryl ester of N-methyldopamine, was compared with that of… 
1986
1986
The present paper reports a study of the effect of ibopamine (SB-7505), the 3,4-diisobutyryl ester of N-methyldopamine (epinine… 
1984
1984
The hemodynamic effects of the dopamine congener, ibopamine, were investigated in nine patients with chronic congestive heart… 
1983
1983
We administered 150 mg of ibopamine orally to 10 patients suffering from idiopathic congestive cardiomyopathy. Hemodynamic…